Cargando…
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treatment modalities including transplant, surgical resection and locoregional therapies including ablative therapies and transarterial embolotherapies. Although transplant and surgical resection offer the...
Autores principales: | Lee, Edward Wolfgang, Khan, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759999/ https://www.ncbi.nlm.nih.gov/pubmed/29113030 http://dx.doi.org/10.3350/cmh.2017.0111 |
Ejemplares similares
-
Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients
por: Xu, Wei, et al.
Publicado: (2019) -
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
por: Chang, Young, et al.
Publicado: (2020) -
Endovascular and Percutaneous Embolotherapy for the Body and Extremity Arteriovenous Malformations
por: Osuga, Keigo, et al.
Publicado: (2023) -
Image-Guided Embolotherapy of Arteriovenous Malformations of the Face
por: Schmidt, Vanessa F., et al.
Publicado: (2022) -
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)